MATH vs SCYX Comparison

Metalpha Technology Holding Ltd is to enable the transition towards digital asset technology. The company aims to provide a crypto derivatives product services for users world-wide. The company has three operating segments. The Longyun operating segment reflects the Company's crowdfunding and incubation business. The Dacheng Liantong operating segment reflects the Company's business of platform services. The Metalpha operating segment reflects the Company's business of proprietary trading of digital assets. The Company is generates its revenue from Hong Kong.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.